Abbisko Cayman (STU:8ZD) Cash-to-Debt : 55.21 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Abbisko Cayman's cash to debt ratio for the quarter that ended in Dec. 2023 was 55.21.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Abbisko Cayman could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Abbisko Cayman's Cash-to-Debt or its related term are showing as below:

STU:8ZD' s Cash-to-Debt Range Over the Past 10 Years
Min: 32.09 Med: 51.62 Max: 143.48
Current: 55.21

During the past 5 years, Abbisko Cayman's highest Cash to Debt Ratio was 143.48. The lowest was 32.09. And the median was 51.62.

STU:8ZD's Cash-to-Debt is ranked better than
72.81% of 1493 companies
in the Biotechnology industry
Industry Median: 6.89 vs STU:8ZD: 55.21

Abbisko Cayman Cash-to-Debt Historical Data

The historical data trend for Abbisko Cayman's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Abbisko Cayman Cash-to-Debt Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

32.10

143.54

47.31

51.62

55.21

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial			47.31	48.26	51.62	53.96	55.21

Competitive Comparison of Abbisko Cayman's Cash-to-Debt

For the Biotechnology subindustry, Abbisko Cayman's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbisko Cayman's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abbisko Cayman's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Abbisko Cayman's Cash-to-Debt falls into.

Abbisko Cayman Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Abbisko Cayman's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	253.312	/	(1.363	+	3.225)
	=	55.21

Abbisko Cayman's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	253.312	/	(1.363	+	3.225)
	=	55.21

Abbisko Cayman (STU:8ZD) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Abbisko Cayman Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbisko Cayman (STU:8ZD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

02256:Hong Kong

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (STU:8ZD) Headlines

No Headlines